M. pneumoniae and C. pneumoniae are no relevant pathogens in critically ill patients with hospital-acquired respiratory tract infections
- 56 Downloads
To assess the incidence of Mycoplasma pneumoniae and Chlamydia pneumoniae in the pathogenesis of hospital-acquired respiratory tract infections (RTIs) in critically ill patients.
This is a retrospective cohort study of all ICU-patients ≥ 18 years with RTI who underwent conventional culture techniques and PCR testing for both M. pneumoniae and C. pneumoniae from respiratory tract specimens (bronchoalveolar lavage or tracheobronchial aspirates) between January 2013 to May 2017 at the Jena University Hospital.
In total, 314 patients were included in the analysis. Of these, 210 (66.9%) patients were diagnosed with HAP, 65 (20.7%) with VAP and 39 (12.4%) with VAT. Overall, 73 (30.7%) patients were on mechanical ventilation on the day of microbiological examination. PCR-testing for M. pneumoniae was positive in two patients (0.6%) and for C. pneumoniae in zero patients.
Our study shows that the incidence of M. pneumoniae and C. pneumoniae in the pathogenesis of hospital-acquired RTIs in critically ill patients is negligible. The results support the recommendations of the guidelines not to perform empiric therapy covering these pathogens.
KeywordsHospital-acquired pneumonia (HAP) Ventilator-associated pneumonia (VAP) Ventilator-associated tracheobronchitis (VAT) Mycoplasma pneumoniae Chlamydia pneumoniae
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests relevant to the manuscript.
- 1.Torres A, Niederman MS, Chastre J, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT). Eur Respir J. 2017;50:1700582.CrossRefGoogle Scholar
- 6.Park DR. The microbiology of ventilator-associated pneumonia. Respir Care. 2005;50:742–63 (discussion 763–5).Google Scholar
- 8.Louie M, Dyck B, Parker S, et al.: Nosocomial pneumonia in a Canadian tertiary care center: a prospective surveillance study. Infect. Control Hosp. Epidemiol. 1991;12:356–63.Google Scholar